Pharmacological and clinical profile of tiotropium bromide (Spiriva®), a new long-acting anticholinergic bronchodilator for COPD treatment

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Folia Pharmacologica Japonica 2005, Vol.125(5), pp.307-313
Hauptverfasser: Ohmura, Tsuyoshi, Nishikawa, Hidekazu
Format: Artikel
Sprache:jpn
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 313
container_issue 5
container_start_page 307
container_title Folia Pharmacologica Japonica
container_volume 125
creator Ohmura, Tsuyoshi
Nishikawa, Hidekazu
description
doi_str_mv 10.1254/fpj.125.307
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_68000264</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68000264</sourcerecordid><originalsourceid>FETCH-LOGICAL-j1497-a1ba584492d31b3cc10b7b9c3e798965ec4cc1310740cfe6e21ffc60f5d6c92e3</originalsourceid><addsrcrecordid>eNo9kc9OGzEQxq0KVCLg1HvlUwVSF-z12o6PKLQUCSmRaM8rr3ccHHntrdcB8Qx9lz5EnwynBA7-MzO_-aSZD6FPlFzQmjeXdtzsPheMyA9oRlkjqzlT8gDNCKG84kLRI3Q6Ta4jhMtaCkY_oiPKlZJUqBn6s3rQadAm-rh2RnusQ4-Nd-F_MKZonQccLc4u5hRHtx1wl-LgesBn96NL7lH_-3v-FWsc4An7GNaVNtmFdVHKzjzEogWpaO_aQol753WOCdtyFsvVNc4JdB4g5BN0aLWf4HT_HqNf37_9XPyo7pY3t4uru2pDGyUrTTvN502j6p7RjhlDSSc7ZRhINVeCg2lKjlEiG2IsCKiptUYQy3thVA3sGH151S3j_d7ClNvBTQa81wHidmrFnBBSi6aAn_fgthugb8fkBp2e27f1FeDqFdhMWa_hHdCpjO6hLe60xZ2W7-_i0nvNlMW3ENgLoT-M2A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68000264</pqid></control><display><type>article</type><title>Pharmacological and clinical profile of tiotropium bromide (Spiriva®), a new long-acting anticholinergic bronchodilator for COPD treatment</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Ohmura, Tsuyoshi ; Nishikawa, Hidekazu</creator><creatorcontrib>Ohmura, Tsuyoshi ; Nishikawa, Hidekazu</creatorcontrib><identifier>ISSN: 0015-5691</identifier><identifier>EISSN: 1347-8397</identifier><identifier>DOI: 10.1254/fpj.125.307</identifier><identifier>PMID: 15997169</identifier><language>jpn</language><publisher>Japan: The Japanese Pharmacological Society</publisher><subject>Animals ; Bronchoconstriction - drug effects ; Bronchodilator Agents - administration &amp; dosage ; Bronchodilator Agents - therapeutic use ; Cholinergic Antagonists - administration &amp; dosage ; Cholinergic Antagonists - therapeutic use ; Humans ; Pulmonary Disease, Chronic Obstructive - drug therapy ; Quality of Life ; Receptors, Muscarinic - drug effects ; Scopolamine Derivatives - administration &amp; dosage ; Scopolamine Derivatives - pharmacology ; Scopolamine Derivatives - therapeutic use ; Tiotropium Bromide</subject><ispartof>Folia Pharmacologica Japonica, 2005, Vol.125(5), pp.307-313</ispartof><rights>2005 by The Japanese Pharmacological Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15997169$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ohmura, Tsuyoshi</creatorcontrib><creatorcontrib>Nishikawa, Hidekazu</creatorcontrib><title>Pharmacological and clinical profile of tiotropium bromide (Spiriva®), a new long-acting anticholinergic bronchodilator for COPD treatment</title><title>Folia Pharmacologica Japonica</title><addtitle>Nihon Yakurigaku Zasshi</addtitle><subject>Animals</subject><subject>Bronchoconstriction - drug effects</subject><subject>Bronchodilator Agents - administration &amp; dosage</subject><subject>Bronchodilator Agents - therapeutic use</subject><subject>Cholinergic Antagonists - administration &amp; dosage</subject><subject>Cholinergic Antagonists - therapeutic use</subject><subject>Humans</subject><subject>Pulmonary Disease, Chronic Obstructive - drug therapy</subject><subject>Quality of Life</subject><subject>Receptors, Muscarinic - drug effects</subject><subject>Scopolamine Derivatives - administration &amp; dosage</subject><subject>Scopolamine Derivatives - pharmacology</subject><subject>Scopolamine Derivatives - therapeutic use</subject><subject>Tiotropium Bromide</subject><issn>0015-5691</issn><issn>1347-8397</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kc9OGzEQxq0KVCLg1HvlUwVSF-z12o6PKLQUCSmRaM8rr3ccHHntrdcB8Qx9lz5EnwynBA7-MzO_-aSZD6FPlFzQmjeXdtzsPheMyA9oRlkjqzlT8gDNCKG84kLRI3Q6Ta4jhMtaCkY_oiPKlZJUqBn6s3rQadAm-rh2RnusQ4-Nd-F_MKZonQccLc4u5hRHtx1wl-LgesBn96NL7lH_-3v-FWsc4An7GNaVNtmFdVHKzjzEogWpaO_aQol753WOCdtyFsvVNc4JdB4g5BN0aLWf4HT_HqNf37_9XPyo7pY3t4uru2pDGyUrTTvN502j6p7RjhlDSSc7ZRhINVeCg2lKjlEiG2IsCKiptUYQy3thVA3sGH151S3j_d7ClNvBTQa81wHidmrFnBBSi6aAn_fgthugb8fkBp2e27f1FeDqFdhMWa_hHdCpjO6hLe60xZ2W7-_i0nvNlMW3ENgLoT-M2A</recordid><startdate>200505</startdate><enddate>200505</enddate><creator>Ohmura, Tsuyoshi</creator><creator>Nishikawa, Hidekazu</creator><general>The Japanese Pharmacological Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200505</creationdate><title>Pharmacological and clinical profile of tiotropium bromide (Spiriva®), a new long-acting anticholinergic bronchodilator for COPD treatment</title><author>Ohmura, Tsuyoshi ; Nishikawa, Hidekazu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-j1497-a1ba584492d31b3cc10b7b9c3e798965ec4cc1310740cfe6e21ffc60f5d6c92e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>jpn</language><creationdate>2005</creationdate><topic>Animals</topic><topic>Bronchoconstriction - drug effects</topic><topic>Bronchodilator Agents - administration &amp; dosage</topic><topic>Bronchodilator Agents - therapeutic use</topic><topic>Cholinergic Antagonists - administration &amp; dosage</topic><topic>Cholinergic Antagonists - therapeutic use</topic><topic>Humans</topic><topic>Pulmonary Disease, Chronic Obstructive - drug therapy</topic><topic>Quality of Life</topic><topic>Receptors, Muscarinic - drug effects</topic><topic>Scopolamine Derivatives - administration &amp; dosage</topic><topic>Scopolamine Derivatives - pharmacology</topic><topic>Scopolamine Derivatives - therapeutic use</topic><topic>Tiotropium Bromide</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ohmura, Tsuyoshi</creatorcontrib><creatorcontrib>Nishikawa, Hidekazu</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Folia Pharmacologica Japonica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ohmura, Tsuyoshi</au><au>Nishikawa, Hidekazu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacological and clinical profile of tiotropium bromide (Spiriva®), a new long-acting anticholinergic bronchodilator for COPD treatment</atitle><jtitle>Folia Pharmacologica Japonica</jtitle><addtitle>Nihon Yakurigaku Zasshi</addtitle><date>2005-05</date><risdate>2005</risdate><volume>125</volume><issue>5</issue><spage>307</spage><epage>313</epage><pages>307-313</pages><issn>0015-5691</issn><eissn>1347-8397</eissn><cop>Japan</cop><pub>The Japanese Pharmacological Society</pub><pmid>15997169</pmid><doi>10.1254/fpj.125.307</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0015-5691
ispartof Folia Pharmacologica Japonica, 2005, Vol.125(5), pp.307-313
issn 0015-5691
1347-8397
language jpn
recordid cdi_proquest_miscellaneous_68000264
source MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Animals
Bronchoconstriction - drug effects
Bronchodilator Agents - administration & dosage
Bronchodilator Agents - therapeutic use
Cholinergic Antagonists - administration & dosage
Cholinergic Antagonists - therapeutic use
Humans
Pulmonary Disease, Chronic Obstructive - drug therapy
Quality of Life
Receptors, Muscarinic - drug effects
Scopolamine Derivatives - administration & dosage
Scopolamine Derivatives - pharmacology
Scopolamine Derivatives - therapeutic use
Tiotropium Bromide
title Pharmacological and clinical profile of tiotropium bromide (Spiriva®), a new long-acting anticholinergic bronchodilator for COPD treatment
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T12%3A28%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacological%20and%20clinical%20profile%20of%20tiotropium%20bromide%20(Spiriva%C2%AE),%20a%20new%20long-acting%20anticholinergic%20bronchodilator%20for%20COPD%20treatment&rft.jtitle=Folia%20Pharmacologica%20Japonica&rft.au=Ohmura,%20Tsuyoshi&rft.date=2005-05&rft.volume=125&rft.issue=5&rft.spage=307&rft.epage=313&rft.pages=307-313&rft.issn=0015-5691&rft.eissn=1347-8397&rft_id=info:doi/10.1254/fpj.125.307&rft_dat=%3Cproquest_pubme%3E68000264%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68000264&rft_id=info:pmid/15997169&rfr_iscdi=true